Sunny Pharmtech Total Current Liabilities

Sunny Pharmtech (6676.TWO) currently reports a total current liabilities of $140M as of June 2026. That compares with $250M in the prior-year period — down 42.4% year over year. Use the charts on this page to explore Sunny Pharmtech's total current liabilities history and peer comparisons.

Sunny Pharmtech's total current liabilities decreased from $250M to $140M — a 42.4% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Sunny Pharmtech reported $140M in total current liabilities as of June 2026. That compares with $250M in the prior-year period — down 42.4% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $140M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sunny Pharmtech, and consider following 6676.TWO for alerts when major investors trade the stock.

Sunny Pharmtech is classified in the Healthcare sector. On total current liabilities, it currently shows $140M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing 6676.TWO with unrelated industries.